GLP-1 RAs Plus Bariatric Surgery:'Promising' for Obesity GLP-1 RAs Plus Bariatric Surgery:'Promising' for Obesity
Liraglutide combined with endoscopic bariatric therapy can provide weight loss on par with bariatric surgery alone, raising the question of whether the GLP-1 RAs might one day replace surgery.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - November 15, 2023 Category: Endocrinology Tags: Gastroenterology News Source Type: news
GLP-1 Agonists Linked to Higher Risk for GI Complications GLP-1 Agonists Linked to Higher Risk for GI Complications
Compared with naltrexone/bupropion for weight loss, semaglutide and liraglutide were associated with a higher risk for three adverse gastrointestinal outcomes.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 5, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Weight-Loss Drugs Come With Serious Side Effects, According to a New Study
There’s been a surge in demand for a class of diabetes drugs that are now popular for their serendipitous byproduct: weight loss.
The drugs belong to a class called GLP-1 agonists and include semaglutide, the main ingredient in Ozempic, Wegovy, and Rybelsus; tirzepatide, which is found in Mounjaro; and liraglutide, used in Victoza and Saxenda. While effective in helping people with diabetes to lose about 15% of their body weight, these drugs are also linked to some risk of gastrointestinal side effects, including inflammation in the pancreas and obstructions of the digestive system.
[time-brightcove not-tgx=”...
Source: TIME: Health - October 5, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Liraglutide Fixes Learning Limit Tied to Insulin Resistance Liraglutide Fixes Learning Limit Tied to Insulin Resistance
A single dose of GLP-1 receptor agonist liraglutide produced short-term correction of a deficit in associative learning found in people with insulin insensitivity and obesity in a controlled study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 24, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Scientists hope weight-loss drugs could treat addiction and dementia
Medications with semaglutide such as Ozempic and Wegovy are being studied to see if they can help other conditionsThey have taken the celebrity world by storm as a slimming jab and become a vital tool for managing type 2 diabetes. Now drugs such as Ozempic are being researched to look at whether they could help conditions ranging from alcohol misuse to dementia.Ozempic, a type 2 diabetes medication, and Wegovy, which is licensed for weight loss, contain the drug semaglutide, while a similar drug, liraglutide, is available for both purposes under different brand names.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 21, 2023 Category: Science Authors: Nicola Davis Tags: Dementia Alcoholism Drugs Health Diabetes UK news Source Type: news
I've been on a weight-loss drug like Ozempic for nearly a DECADE. The good, bad and ugly, this is what you can expect
Danielle Payton, 33, from Florida, started taking diabetes injection Victoza (inset) in 2014. She lost nearly 100 pounds but worries people taking the drugs unnecessarily are causing shortages. (Source: the Mail online | Health)
Source: the Mail online | Health - August 4, 2023 Category: Consumer Health News Source Type: news
Poor Weight Loss After Bariatric Surgery? Liraglutide May Help Poor Weight Loss After Bariatric Surgery? Liraglutide May Help
Added weight loss with liraglutide is ' extremely welcomed, ' with new antiobesity medications being ' another effective tool in the toolbox for the treatment of severe obesity, ' say experts.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 26, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Saxenda Shortage; New ADA Guidance; Cheap Test for Osteoporosis Risk?
(MedPage Today) -- The shortage of weight-loss drugs now extends to liraglutide (Saxenda). (Fierce Pharma)
Compared with DPP-4 inhibitors, SGLT2 inhibitors helped reduce recurrent gout flare-ups and hospitalizations in people with type 2 diabetes... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - July 25, 2023 Category: Endocrinology Source Type: news
Evidence Weighed for Suicide/Self-Harm With Obesity Drugs Evidence Weighed for Suicide/Self-Harm With Obesity Drugs
As the EU looks into cases of suicidal thoughts and self-harm associated with the GLP-1 agonists semaglutide, and liraglutide, Novo Nordisk says it is confident of the risk-benefit profile of these agents.Medscape Medical News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - July 12, 2023 Category: Pediatrics Tags: Diabetes & Endocrinology News Source Type: news
Weight Loss Drugs and Suicide; Air Monitor Detects COVID; Fecal Bacteria at Beaches
(MedPage Today) -- Note that some links may require subscriptions.
The European Medicines Agency is investigating weight loss and diabetes drugs semaglutide (Ozempic) and liraglutide (Saxenda) over reports of suicidal thoughts. (NBC News)
Pharmacy... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 11, 2023 Category: American Health Source Type: news
More Weight Loss Drugs Are Coming, And They Could Be Even More Effective
Weight loss drugs are having a moment, owing to the fact that pharmaceutical companies have figured out how to help people lose up to double-digit percentages of their body weight and start dropping a more substantial number of pounds.
Although Ozempic, Wegovy, and Rybelsus, all Novo Nordisk products, have dominated the market in the past year, Eli Lilly has its own pipeline of obesity medications. And new data the company revealed on June 23 suggest its products could give doctors and patients a greater range of options for treating the chronic condition—including more options in the form of pills, which could make ...
Source: TIME: Health - June 26, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Drugs healthscienceclimate Source Type: news
Semaglutide Bests Liraglutide for Post-Surgery Weight Regain Semaglutide Bests Liraglutide for Post-Surgery Weight Regain
Once-weekly semaglutide produced over twice the weight loss as did daily liraglutide for people who regained weight after metabolic/bariatric surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2023 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Semaglutide Better Than Liraglutide for Post-Bariatric Surgery Weight Recurrence
WEDNESDAY, June 7, 2023 -- Semaglutide is associated with superior weight loss for treating post-metabolic and bariatric surgery (MBS) weight recurrence compared with liraglutide, according to a study published in the May issue of Obesity.
Natia... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2023 Category: Pharmaceuticals Source Type: news
Obesity Drug With Swallowable Balloon Boosts Weight Loss Obesity Drug With Swallowable Balloon Boosts Weight Loss
A combination of a swallowable Allurion gastric balloon and liraglutide delivers higher weight loss (around 19% after mean 4 months) than use of separate treatments.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - May 18, 2023 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
Weight Loss Drug Saxenda May Make WHO List: Could Help Make It Cheaper Worldwide
Liraglutide has been approved for weight loss since 2014 by the FDA. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 31, 2023 Category: Pharmaceuticals Authors: Arianna Johnson, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Breaking breaking-news Trending Explainer Trending-Explainer Source Type: news
